Medigene

Developer of T cell immunotherapies for haematological malignancies

placePlanegg, Bavaria, Germany calendar_todayFounded 1994 groups114 employees language medigene.com

Registered entities

Investor mix

7 investors on record.

Investor typeCountShare
Venture capital686%
Private equity114%
Coming soon